Comparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women
NCT ID: NCT04962971
Last Updated: 2022-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
216 participants
OBSERVATIONAL
2020-09-01
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study objective is to collect in real life efficacy and tolerance data from the consumption of 3 cranberry extracts in order to highlight the qualitative and quantitative characteristics of these extracts which are directly involved in the improvement of urinary discomfort or situation of recurrent cystitis symptomatic episodes in women.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)
NCT00100061
Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics
NCT04987164
Cranberry for the Prevention of Urinary Tract Infections
NCT02454309
Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections
NCT03019874
Cranberry for the Prevention of Urinary Tract Infections
NCT05730998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cranberry extract X
373 mg per Day
X
exocyan
Cranberry extract Y
404 mg per Day
Y
exocyan
Cranberry extract Z
2090 mg per Day
Z
exocyan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
X
exocyan
Y
exocyan
Z
exocyan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* whose episode had a significant impact on quality of life / urinary discomfort (ACSS Dimension QoL ≥ 2)
* had a smartphone compatible with Nurstrial smartphone application (e-CRF)
Exclusion Criteria
* currently taking any other supplementation for urinary comfort or having taken any other cranberry-based food supplement in the past 3 months,
* to be under antibiotic treatment or during the last 7 days preceding inclusion,
* have urinary discomfort with a severe impact on quality of life (ACSS QoL\> 7) during the last 24 hours prior to inclusion,
* have an allergy known to plants of the cranberry family or to one of the components of the products.
18 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nexira
INDUSTRY
CEN Nutriment
UNKNOWN
CEN Biotech
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine JUHEL
Role: STUDY_DIRECTOR
CEN Nutriment
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CEN Nutriment
Dijon, Burgundy, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C1635
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.